Skip to main content

What the FDA labels say about taking them together

Eluxadoline and rifampin

Eluxadoline's FDA label of July 16, 2024 names rifampin in its drug interactions section; the rifampin label PlainMeds reads does not name eluxadoline. The eluxadoline label: “Increased exposure to eluxadoline when coadministered with cyclosporine [ see Clinical Pharmacology () ]”

Check it at the source: the eluxadoline FDA label on DailyMed (effective July 16, 2024, Allergan, Inc.); the rifampin FDA label on DailyMed (effective February 11, 2026, Lupin Pharmaceuticals, Inc.).

What does the eluxadoline label say about rifampin?

Eluxadoline label, drug interactions

OATP1B1 Inhibitors Clinical Impact: Increased exposure to eluxadoline when coadministered with cyclosporine [ see Clinical Pharmacology () ] … cyclosporine, gemfibrozil, antiretrovirals (atazanavir, lopinavir, ritonavir, saquinavir, tipranavir), rifampin, eltrombopag

Source: FDA drug label (Viberzi), NDA206940 (Abbvie), as published by Allergan, Inc., effective July 16, 2024 (SPL set 7821bd40-4c84-4984-951b-6436ae20421a), via openFDA; the full label on DailyMed

What does the rifampin label say about eluxadoline?

Rifampin's label (effective February 11, 2026) does not name eluxadoline in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (rifampin), Lupin Pharmaceuticals, Inc., effective February 11, 2026 (SPL set b56004f0-f23d-47f6-80c7-39884fccbccc), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Eluxadoline generic labelers
13Rifampin generic labelers
EluxadolineRifampin
Labeled forIrritable bowel syndrome, Diarrhean/a
Boxed warningNoNo
Pharmacy cost (NADAC)$28.09 per tablet 100 mg tablet$0.679 per capsule 300 mg capsule
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?